Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases

被引:22
作者
Broyde, Adi [1 ]
Arad, Uri [1 ]
Madar-Balakirski, Noa [1 ]
Paran, Daphna [1 ]
Kaufman, Ilana [1 ]
Levartovsky, David [1 ]
Wigler, Irena [1 ]
Caspi, Dan [1 ]
Elkayam, Ori [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Rheumatol, Tel Aviv Med Ctr, IL-69978 Tel Aviv, Israel
关键词
PNEUMOCOCCAL; VACCINE; AUTOIMMUNE; EFFICACY; RHEUMATOID ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PNEUMOCOCCAL ANTIBODY-LEVELS; INFLUENZAE TYPE-B; BACTERIAL-MENINGITIS; PSORIATIC-ARTHRITIS; IMMUNOGENICITY; ADULTS; REVACCINATION; PERSISTENCE; MORTALITY;
D O I
10.3899/jrheum.150397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To estimate the longterm humoral response of an antipneumococcal polysaccharide vaccine (PPSV23) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), or inflammatory bowel disease (IBD)-associated spondyloarthropathy (SpA), and the effect of demographic and clinical factors and treatment on the longterm efficacy of the vaccine. Methods. A total of 145 consecutive patients treated with biologics [tumor necrosis factor-alpha (TNF-alpha) or interleukin 6 (IL-6) receptor inhibitors] or methotrexate (MTX) participated in this study. Fifteen were excluded because of absent information regarding their vaccination status (n = 9) or because of technical problems in obtaining their serum sample (n = 6). They were diagnosed with RA (n = 63, 48.5%), PsA (n = 29, 22.3%), AS (n = 28, 21.5%), or IBD-associated SpA (n = 3, 2.3%). Their mean age was 54.6 years, and 61.5% were women. Data were collected on the timing of vaccination, demographic and clinical characteristics, and treatment, and patients' serum antipneumococcal antibody levels were tested. Results. Two-thirds of the patients (67.7%) had received PPSV23 45 months (mean) earlier. Treatment included TNF-alpha inhibitors (73.9%), IL-6 receptor inhibitors (13.1%), or MTX without a biological treatment (13%). The uptake of vaccination was significantly higher in the older population (> 65 yrs). Vaccinated patients had significantly higher antibody levels compared with vaccine-naive patients. The antibody levels had been preserved after 10 years. MTX use, but not biologics, was associated with significantly lower antibody levels. Conclusion. The longterm efficacy of the PPSV23 vaccination seems to be preserved among patients with RA, PsA, AS, and IBD-associated SpA for at least 10 years. Efficacy is slightly impaired by MTX, but it is not affected by biologics. These findings suggest that revaccination after 5 years might not be needed for all, and testing the antibody titers should be considered to identify those who may benefit from revaccination.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 41 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]  
Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816
[3]   Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial [J].
Bingham, Clifton O., III ;
Looney, R. John ;
Deodhar, Atul ;
Halsey, Neal ;
Greenwald, Maria ;
Codding, Christine ;
Trzaskoma, Benjamin ;
Martin, Flavius ;
Agarwal, Sunil ;
Kelman, Ariella .
ARTHRITIS AND RHEUMATISM, 2010, 62 (01) :64-74
[4]   Infections in systemic lupus erythematosus:: a prospective and controlled study of 110 patients [J].
Bosch, X. ;
Guilabert, A. ;
Pallares, L. ;
Cervera, R. ;
Ramos-Casals, M. ;
Bove, A. ;
Ingelmo, M. ;
Font, J. .
LUPUS, 2006, 15 (09) :584-589
[5]   Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil [J].
Brandao, AP ;
de Oliveira, TC ;
Brandileone, MCD ;
Gonçalves, JE ;
Yara, TI ;
Simonsen, V .
VACCINE, 2004, 23 (06) :762-768
[6]   PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY - AN EVALUATION OF CURRENT RECOMMENDATIONS [J].
BUTLER, JC ;
BREIMAN, RF ;
CAMPBELL, JF ;
LIPMAN, HB ;
BROOME, CV ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15) :1826-1831
[7]   Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Mejía, JC ;
Aydintug, AC ;
Chwalinska-Sadowska, H ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Valen, M ;
Mathieu, A ;
Houssiau, FD ;
Caro, N ;
Alba, P ;
Ramos-Casals, M ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 2003, 82 (05) :299-308
[8]   Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate [J].
Coulson, Elizabeth ;
Saravanan, Vadivelu ;
Hamilton, Jennifer ;
Long, Kin So ;
Morgan, Lynn ;
Heycock, Carol ;
Rynne, Martin ;
Kelly, Clive .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) :1289-1291
[9]   Dexamethasone in adults with bacterial meningitis. [J].
de Gans, J ;
van de Beek, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1549-1556
[10]   Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study [J].
Doran, MF ;
Crowson, CS ;
Pond, GR ;
O'Fallon, WM ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2287-2293